NCT05527964已完成不适用
The Influence of Specific Targeted Therapy on Subject and Family Quality of Life, Anxiety, Depression and Sleep Quality in Patients With Severe Refractory Atopic Dermatitis in the Czech Republic
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 146
- 试验地点
- 1
- 主要终点
- The regression coefficient for at least 75% reduction in the Eczema Area and Severity Index score (EASI75) at week 24 adjusted to baseline characteristics predicting the change in EQ-5D utility
研究概览
简要总结
Assessment of the relationship between treatment response (EASI75) and change in quality of life (EQ-5D) by week 24.
Description of the:
- Change in disease activity after 16 and 24 weeks
- Change in subject and family quality of life after 16 and 24 weeks
- Change in sleep quality after 16 and 24 weeks
- Change in anxiety after 16 and 24 weeks
- Change in depression after 16 and 24 weeks
- Safety and tolerability
详细描述
28 weeks
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient eligible for Dupixent therapy of AD according to the current SPC and reimbursement criteria given by the SUKL
- •Signed informed consent
- •18 years and older (study questionnaires are validated for this age group). Patient is able to follow the prescribed regimen, routine follow-up visits and to fill the questionnaires
排除标准
- •Patient not eligible for Dupixent therapy of AD according to the current SPC and reimbursement criteria given by the SUKL.
- •The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.
结局指标
主要结局
The regression coefficient for at least 75% reduction in the Eczema Area and Severity Index score (EASI75) at week 24 adjusted to baseline characteristics predicting the change in EQ-5D utility
时间窗: At Week 24
次要结局
- Total number of adverse events(At Week 16 and Week 24)
- Change in anxiety (Clinically Useful Anxiety Outcome Scale (CUXOS) score)(At Week 16 and Week 24)
- Change in disease activity (Eczema Area and Severity Index (EASI) score)(At Week 16 and Week 24)
- Reasons for discontinuations(At Week 16 and Week 24)
- Change in subject generic quality of life (European Quality of Life Five Dimension questionnaire (EQ-5D) utility)(At Week 16 and Week 24)
- Change in Family Dermatology Life Quality Index (FDLQI score)(At Week 16)
- Change in sleep quality (Jenkins Sleep Evaluation Questionnaire (JSEQ) score)(At Week 16 and Week 24)
- Total number of discontinuations(At Week 16 and Week 24)
- Change in Dermatology Life Quality Index (DLQI score)(At Week 16 and Week 24)
- Change in depression (Clinically Useful Depression Outcome Scale (CUDOS) score)(At Week 16 and Week 24)
- Number of non-serious adverse events (non-SAEs)(At Week 16 and Week 24)
- Number of serious adverse events (SAEs)(At Week 16 and Week 24)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Effect of targeted psychotherapy on quality of life outcomes in palliative care patientsPACTR201604001447244Agakhan University Hospital144
已完成
不适用
Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative ColitisIBD-Inflammatory Bowel DiseaseUC - Ulcerative ColitisNCT05271773Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa234
Enrolling By Invitation
不适用
Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral RetinoblastomaSurvivors of Unilateral RetinoblastomaNCT03662776Memorial Sloan Kettering Cancer Center120
Unknown
不适用
Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their CaregiversSchizophreniaNCT02868307Assistance Publique Hopitaux De Marseille200
招募中
不适用
Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent GraftsJuxtarenal Aortic AneurysmsSuprarenal Aortic AneurysmsType IV Thoracoabdominal Aortic AneurysmsNCT01937949Gustavo Oderich200